Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Amba Hotel Marble Arch

Dec 07, 2016 9:00 AM - Dec 08, 2016 3:30 PM

Bryanston Street , London, W1H 7EH, United Kingdom

Clinical Trial Disclosure & Data Transparency Conference

Discuss and learn about disclosure strategy, developing operational measures, and find efficient ways to manage dissemination of clinical trial protocol information and results data. Turn challenges into wins!

Overview

Transparency of clinical trial information is taking on new dimensions, including the release of anonymised participant-level data and return of results to study participants. Clinical trial sponsors and academia are facing a host of new registration requirements in the EU and the US. There is a call to share their clinical trial data and industry’s initiatives on data sharing are also expanding. This increased transparency and use of information from clinical trials brings with it new data use opportunities and operational challenges for industry and academia.

The continuing expansion of disclosure requirements in the US and EU leave many sponsors and academia considering disclosure strategy, developing operational measures, and looking for efficient ways to manage dissemination of clinical trial protocol information and results data. The users of clinical trial information is varied which provides both opportunities and challenges for how the information is provided.

Featured

Want to learn more about Clinical Trial Disclosure & Data Transparency Conference? You've come to the right site!

Exhibits

Learning objectives

  • Learn about the latest developments relating to the EU Clinical Trial Regulation and its impact on transparency, and trends in the global clinical trial disclosure world
  • Benefit from the various perspectives on clinical trial transparency of large, mid-sized, and smaller sponsor organizations
  • Leverage best practices on implementation of clinical trial disclosure through case studies by exchanging views between regulators, industry, patients, academia and other stakeholders

Program Committee

  • Robert  Paarlberg, MS
    Robert Paarlberg, MS Principal
    Paarlberg & Associates LLC, United States
  • Merete  Joergensen, MBA, MSc
    Merete Joergensen, MBA, MSc Clinical Disclosure and Transparency Expert, Former EFPIA, CREG Clinical Trials
    Merete-J Consulting CVR: 34920818, Denmark
  • Gerard  Lynch
    Gerard Lynch Associate Director, Clinical Operations
    Biogen, United Kingdom
  • Matthias  Zerm, PhD
    Matthias Zerm, PhD Lead Expert, Clinical Trial Disclosure and R&D Processes
    Germany

Digital Learning Catalog

DIA Learning: eLearning Soultions
Download

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.